Literature DB >> 30292882

Generation of an induced pluripotent stem cell (iPSC) line from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Leu328Val) mutation.

Niklas Schwarz1, Betül Uysal2, Filip Rosa2, Heidi Löffler2, Ulrike A Mau-Holzmann3, Stefan Liebau4, Holger Lerche2.   

Abstract

Mutations in the KCNA2 gene, coding for the voltage-gated K+ channel Kv1.2, can cause developmental and epileptic encephalopathies. Kv1.2 channels play an important role in the repolarization phase of an action potential in nerve cells. Here, we reprogrammed human skin fibroblasts from a 13-year-old male patient with developmental and epileptic encephalopathy carrying a point mutation (c.982T>G, p.Leu328Val) in KCNA2 to human induced pluripotent stem cells (iPSCs) (HIHDNEi001-A). The cells maintained a normal karyotype and their pluripotency state was verified by the expression and staining of several pluripotency markers and capability to differentiate into all three germ layers.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30292882     DOI: 10.1016/j.scr.2018.08.019

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  2 in total

Review 1.  Modeling Epilepsy Using Human Induced Pluripotent Stem Cells-Derived Neuronal Cultures Carrying Mutations in Ion Channels and the Mechanistic Target of Rapamycin Pathway.

Authors:  Octavia Yifang Weng; Yun Li; Lu-Yang Wang
Journal:  Front Mol Neurosci       Date:  2022-03-10       Impact factor: 5.639

2.  Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders.

Authors:  Jan H Döring; Julian Schröter; Jerome Jüngling; Saskia Biskup; Kerstin A Klotz; Thomas Bast; Tobias Dietel; G Christoph Korenke; Sophie Christoph; Heiko Brennenstuhl; Guido Rubboli; Rikke S Møller; Gaetan Lesca; Yves Chaix; Stefan Kölker; Georg F Hoffmann; Johannes R Lemke; Steffen Syrbe
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.